Current Oncology (Jul 2024)

HPV Self-Sampling for Cervical Cancer Screening in Under-Screened Saskatchewan Populations: A Pilot Study

  • Erin Vink,
  • Gabriella Antaya,
  • Camille Hamula,
  • Carla Holinaty,
  • Jessica Minion,
  • Gregory R. Pond,
  • Sabryna McCrea,
  • Lynn Dwernychuk,
  • Holly Graham,
  • Gordon Broderick,
  • Mary Kinloch,
  • Jennifer Brown Broderick

DOI
https://doi.org/10.3390/curroncol31080317
Journal volume & issue
Vol. 31, no. 8
pp. 4261 – 4269

Abstract

Read online

Of all cancers in female Canadians, the most rapidly increasing incidence is that of cervical cancer. The objective of this pilot study was to assess how HPV self-sampling might improve cervical cancer screening participation in both urban and rural settings in Saskatchewan, one of the most sparsely populated provinces in Canada. Study groups consisted of n = 250 participants to whom self-swabbing kits were mailed with instructions and n = 250 participants to whom kits were handed out in 6 urban and rural clinics. The inclusion criteria selected subjects aged 30–69 years who were Saskatchewan residents for at least 5 years with valid health coverage, had a cervix, and had no record of cervical cancer screening in 4 years. The returned samples were analyzed for specific HPV strains using the Roche Molecular Diagnostics Cobas 4800® System. The overall response rate was ~16%, with the response to the handout distribution being roughly double that of the mailout. While HPV positivity did not differ across the distribution groups, participants at a specific inner-city clinic reported significantly higher positivity to at least one HPV strain as compared to any other clinic and all mailouts combined. For this high-risk population, in-person handout of self-sampling kits may be the most effective means of improving screening.

Keywords